Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines
Press release content from Business Wire. The AP news staff was not involved in its creation.
Massachusetts Institute Of Technology United States Kevin Friedman Thomas Galbo Molly Perkins Michele Rozen
Source: apnews.com